Proceedings of the 2019 Viral Clearance Symposium, Session 1: Viral Clearance Strategies and Case Studies

References

1. 1.↵
   European Medicines Agency, Guideline on Virus Safety Evaluation of Biotechnological Investigation Medicinal Products. EMA: London, 2008.
2. 2.↵
   U.S. Food and Drug Administration, Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use. Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services: Rockville, MD, 1997.
3. 3.↵
   1. Sipple P.,
   2. Nguyen T.,
   3. Patel K.,
   4. Jaffe N.,
   5. Chen Y.,
   6. Khetan A.

   Suitability of a Generic Virus Safety Evaluation for Monoclonal Antibody Investigational New Drug Applications. Biotechnol. Prog. 2019, 35 (5), e2850.

   OpenUrl
4. 4.↵
   1. Schwantes A.,
   2. Specht R.,
   3. Chen Q.

   Proceedings of the 2017 Viral Clearance Symposium, Session 4: Submission Strategies. PDA J. Pharm. Sci. Technol. 2018, 72 (5), 498–510.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Kreil T. R.,
   2. Roush D.

   Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations—Virus Filtration/Inactivation. PDA J. Pharm. Sci. Technol. 2018, 72 (5), 470–478.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Mattila J.,
   2. Clark M.,
   3. Liu S.,
   4. Pieracci J.,
   5. Gervais T. R.,
   6. Wilson E.,
   7. Galperina O.,
   8. Li X.,
   9. Roush D.,
   10. Zoeller K.,
   11. Brough H.,
   12. Simpson-Platre C.

   Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration. PDA J. Pharm. Sci. Technol. 2016, 70 (3), 293–299.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   ASTM International. ASTM E2888–12 Standard Practice for Process for Inactivation of Rodent Retrovirus by pH. ASTM: West Conshohocken, PA, 2012.
8. 8.↵
   ASTM International. ASTM E3042 Standard Practice for Process Step to Inactivate Rodent Retrovirus with Triton X-100 Treatment. ASTM: West Conshohocken, PA, 2016.
9. 9.↵
   PDA Virus Filtration Task Force. PDA Technical Report No. 41, Revised 2008: Virus Filtration. PDA J. Pharm. Sci. Technol. 2008, 62 (S-4).
10. 10.↵
    1. Miesegaes G.,
    2. Lute S.,
    3. Brorson K.

    Analysis of Viral Clearance Unit Operations for Monoclonal Antibodies. Biotechnol. Bioeng. 2010, 106 (2), 238–246.

    OpenUrlPubMed
11. 11.↵
    International Conference for Harmonisation, Q5A(R1) Step 5, Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. ICH: Geneva, 1997.
12. 12.↵
    1. Wulff N. H.,
    2. Tzatzaris M.,
    3. Young P. J.

    Monte Carlo Simulation of the Spearman- Kaerber TCID50. J. Clin. Bioinf. 2012, 2 (1), 5.

    OpenUrl
13. 13.↵
    European Medicines Agency, Meeting Report: Joint BWP/QWP Workshop with Stakeholders in Relation to Prior Knowledge and Its Use in Regulatory Applications. EMA: London, 2018.